Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 11, 2006

View Archived Issues

GTC awarded SBIR grant for work on CD137 monoclonal antibody

Aegerion signs crosslicense agreement for MTP inhibitors

Shire reviews six months ended June 30, 2006

Wockhardt reports the antibacterial potential of their novel oxazolidinones

Rotigotine transdermal patch yields reduction in RLS symptoms

Pivotal Yondelis study in ovarian cancer recommended to continue

SIGA Technologies terminates merger agreement with PharmAthene

Valentis and Urigen sign merger agreement

Sinclair Pharma and Intendis sign marketing agreement for Atopiclair

Virax advances towards phase II trial of VIR-201 therapeutic HIV vaccine

Pfizer to acquire PowderMed

Novel antihypertensives imparted by Novartis and NitroMed

New selective dual alpha1A/1D adrenoreceptor antagonists reported by Janssen

New agents for endocrine-related disorders imparted in recent patent literature

Completion of phase II Friedreich's ataxia study of idebenone

Clinical hold lifted on CX-717

Lofexidine studied for treatment of opiate withdrawal symptoms in phase III trial

Treatment under way in BrachySil study in inoperable pancreatic cancer

Omrix and NIAID sign avian influenza CRADA

TD-5108 begins phase II for GI motility dysfunction

Can-Fite to develop CF-102 for liver cancer

Ispinesib activity modest in head and neck squamous cell carcinoma

MK-0608: a robust and durable anti-HCV candidate

Adecatumumab assessed in phase II breast and prostate cancer trials

New topoisomerase inhibitor NSC-727357 exhibits antitumor activity

PharmaMar reports clinical results for kahalalide F, plitidepsin and trabectedin

Desoxypeganine shows good pharmacokinetic profile in healthy volunteers

Preclinical data of Basilea's novel macrolide BAL-19403 presented

Grapefruit juice consumption could help to prevent osteoporosis

R&D highlights from the UBS Global Life Sciences Conference in New York: Hana Biosciences

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...